Shares of Optimer Pharmaceuticals (Nasdaq: OPTR) have fallen sharply today following news early yesterday that the results from a Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE